Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2014-05-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD004272.PUB3PMID 35658165PMCID PMC9645779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Published by John Wiley & Sons Ltd

  2015cited by this paper
• A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.

  2011cited by this paper
• A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up.

  2011cited by this paper
• Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Guidance on cancer services : improving outcomes in breast cancer - manual update.

  2009cited by this paper
• Breast cancer in older women: trials and tribulations.

  2009cited by this paper
• Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective

  2008cited by this paper
• Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).

  2006cited by this paper
• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  2005cited by this paper
• Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines

  2004cited by this paper
• Late follow‐up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

  2004cited by this paper
• Undertreatment strongly decreases prognosis of breast cancer in elderly women.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial.

  2003cited by this paper
• Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.

  2003cited by this paper
• The need for targeted research into breast cancer in the elderly

  2003cited by this paper
• Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.

  2003cited by this paper
• Tamoxifen as the primary treatment in elderly patients with breast cancer

  2002cited by this paper
• Results of Adjuvant Treatment in Breast Cancer Women Aged More than 70: Italian Cooperative Group Experience

  2002cited by this paper
• Anastozole (A) is superior to tamoxifen (T) in treatment of postmenopausal (PM) women with early breast cancer (EBC) - First results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial (on behalf of the ATAC Trialists' Group)

  2002cited by this paper
• Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.

  2002cited by this paper
• Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

  2001cited by this paper
• Breast cancer in the elderly: Surgery improves survival. The results of a cancer research campaign trial

  2001cited by this paper
• Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.

  2001cited by this paper
• Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study

  2000cited by this paper
• Tumor characteristics and clinical outcome of elderly women with breast cancer.

  2000cited by this paper
• Implementing clinical practice guidelines: a community‐based audit of breast cancer treatment

  2000cited by this paper
• What threshold for adjuvant therapy in older breast cancer patients?

  2000cited by this paper
• Implementing clinical practice guidelines: a community-based audit of breast cancer treatment. Australian Capital Territory and South Eastern New South Wales Breast Cancer Treatment Group.

  2000cited by this paper
• Management of breast cancer in the elderly by complete local excision and tamoxifen alone.

  1999cited by this paper
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

  1998cited by this paper
• Comments on Costs of treating advanced colorectal cancer, Ross et al., Eur J Cancer 1996, 32A, S13-S17.

  1998cited by this paper
• Le traitement du cancer du sein après 70 ans. A propos de 1143 cas

  1998cited by this paper
• Long term survival in elderly breast cancer patients treated with tamoxifen (TAM) alone vs surgery followed by TAM

  1998cited by this paper
• Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials

  1998cited by this paper
• [Treatment of breast cancer after 70 years of age. Report of 1143 cases].

  1998cited by this paper
• Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer

  1997cited by this paper
• Exclusion of elderly people from clinical research: a descriptive study of published reports

  1997cited by this paper
• Is surgical management compromised in elderly patients with breast cancer?

  1997cited by this paper
• Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer

  1997cited by this paper
• 0-71. Combination rivizor® (vorozole) and ZoladexTM (goserelin) in premenopausal breast cancer: towards maximal oestrogen deprivation

  1997cited by this paper
• A prospective audit of simple mastectomy under local anaesthesia.

  1996cited by this paper
• 93. Breast cancer in the elderly patient — the case for clinical trials

  1995cited by this paper
• Treatment of breast cancer in elderly patients

  1995cited by this paper
• The importance of the lumpectomy surgical margin status in long term results of breast conservation

  1995cited by this paper
• Quality of Life in the Elderly Woman with Breast Cancer Treated with Tamoxifen and Surgery or Tamoxifen Alone

  1994cited by this paper
• The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer

  1994cited by this paper
• Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.

  1994cited by this paper
• Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly.

  1994cited by this paper
• Breast cancer care in old age: what we know, don't know, and do.

  1993cited by this paper
• Surgery versus tamoxifen in selected elderly patients with operable breast cancer: Early results of a randomised trial

  1992cited by this paper
• Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up.

  1992cited by this paper
• Indications for primary tamoxifen therapy in elderly women with breast cancer

  1992cited by this paper
• Treatment Patterns in Elderly Patients (≥70 YEARS) with Breast Carcinoma. A Retrospective Study of the Gruppo Oncologico Clinico Cooperativo del Nord-est (Goccne)

  1991cited by this paper
• Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone

  1991cited by this paper
• Treatment of breast cancer in elderly patients.

  1990cited by this paper
• Tamoxifene (TAM) and primary breast cancer in old women

  1990cited by this paper
• Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.

  1989cited by this paper
• BREAST CANCER, TAMOXIFEN, AND SURGERY

  1988cited by this paper
• Breast cancer, tamoxifen, and surgery.

  1988cited by this paper
• Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.

  1988cited by this paper
• Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

  1988cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Relationship of Age and Menopausal Status to Estrogen Receptor Content in Primary Carcinoma of the Breast

  1983cited by this paper
• Primary treatment of breast cancer in elderly women with Tamoxifen.

  1983cited by this paper
• Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.

  1982cited by this paper
• Double labelling assay system for oestrogen and progesterone receptors.

  1982cited by this paper
• Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality.

  1980cited by this paper
• The treatment of operable breast cancer in the elderly female.

  1978cited by this paper
• A standardized psychiatric interview for use in community surveys.

  1970cited by this paper

• Surgery in Older Cancer Patients

  2026cites this paper
• A Single-Center 11-Year Experience of Surgical Management of Breast Cancer in Patients Aged 90 Years or Older

  2025cites this paper
• Development and validation of novel machine learning-based prognostic models and propensity score matching for comparison of surgical approaches in mucinous breast cancer

  2025cites this paper
• What makes a 'good' mastectomy? - A national qualitative study of health care professionals opinions on mastectomy without reconstruction.

  2025cites this paper
• Effect of surgery on breast cancer-specific mortality in older adults with endocrine receptor-positive and HER2-negative breast cancer

  2025cites this paper
• De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers

  2025cites this paper
• Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis

  2025influential citation
• Evaluating clinical response to primary endocrine therapy in elderly breast cancer patients in routine practice

  2025cites this paper
• Acceptance and Results of Cryoablation for the Treatment of Early Breast Cancer in Non-Surgical Patients.

  2024cites this paper
• Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET)

  2024cites this paper
• Endocrine therapy for cancer

  2024cites this paper
• Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.

  2023cites this paper
• Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer.

  2023cites this paper
• Locoregional Ablative Radiotherapy for Breast Cancer Patients Unsuitable for Surgical Resection.

  2023cites this paper
• Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy

  2023cites this paper
• Cost effectiveness modelling of surgery plus adjuvant endocrine therapy versus primary endocrine therapy alone in UK women aged 70 and over with early breast cancer

  2023influential citation
• Cáncer de mama en pacientes octogenarias

  2022cites this paper
• Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women

  2022cites this paper
• Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT

  2022cites this paper
• Is there evidence of age bias in breast cancer health care professionals' treatment of older patients?

  2022cites this paper
• Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis

  2022cites this paper
• Long-Term Outcome of Sustained Endocrine Monotherapy for Elderly Breast Cancer Patients

  2022cites this paper
• Breast cancer

  2022cites this paper
• The impact of tumour biology on the management of primary breast cancer in older women—based on a research programme in Nottingham

  2021cites this paper
• Adequate Assessment Can Affect the Management of Breast Cancer in Geriatric Population

  2021cites this paper
• Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices

  2021cites this paper
• Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival

  2021cites this paper
• Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer.

  2021cites this paper
• Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).

  2021cites this paper
• The impact of breast cancer surgery on functional status in older women - A systematic review of the literature.

  2021cites this paper
• Management of Early Stage Breast Cancer: Basics and Controversies

  2021cites this paper
• 'Bridging the Age Gap in Breast Cancer: Cluster randomised trial of the effects of two decision support interventions for older women with operable breast cancer on quality-of-life, survival, decision-quality and treatment choices'

  2021cites this paper
• This is a repository copy of Case-mix analysis and variation in rates of non-surgical treatment of older women with operable breast cancer

  2021cites this paper
• into in

  2021cites this paper
• This is a repository copy of Primary endocrine therapy as a treatment for older women with operable breast cancer – a comparison of randomised controlled trial and cohort

  2021cites this paper
• This is a repository copy of Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort

  2021cites this paper
• Treatment and survival outcome of older women with primary breast cancer: a retrospective study of single center

  2021cites this paper
• Neoadjuvant Endocrine Therapy for Operable Breast Cancer: A Retrospective Analysis of Real-World Use

  2021cites this paper
• Delays in operative management of early-stage, estrogen receptor–positive breast cancer during the COVID-19 pandemic: A multi-institutional matched historical cohort study

  2021cites this paper
• Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

  2021cites this paper
• Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancer.

  2021cites this paper
• Neoadjuvant endocrine therapy in women with operable breast cancer: A retrospective analysis of real-world use.

  2021cites this paper
• Breast Cancer in Women Over 65 years- a Review of Screening and Treatment Options.

  2021cites this paper
• Primary endocrine treatment for breast cancer in the elderly

  2020cites this paper
• Preoperative Endocrine Therapy

  2020cites this paper
• The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients—Part II: Metastatic Disease

  2020cites this paper
• De-Escalation of Local-Regional Therapy for Older Breast Cancer Patients

  2020cites this paper
• Principles of Cancer Surgery in Older Adults

  2020cites this paper
• The Impact of the COVID‐19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives

  2020cites this paper
• Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life

  2020cites this paper
• The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients—Part I: Early-Stage Disease

  2020cites this paper
• Age-related disparities in older women with breast cancer.

  2020cites this paper
• Optimal treatment duration of neoadjuvant endocrine therapy in women aged 60 years or older with estrogen receptor-positive, HER2-negative invasive breast cancer.

  2020cites this paper
• Endocrine Therapy in Early Breast Cancer

  2020cites this paper
• Challenges with the management of older patients with cancer during the COVID-19 pandemic

  2020cites this paper
• Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer

  2020cites this paper
• Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women

  2020cites this paper
• Protocol for a Systematic Review Assessing Surgery versus Primary Endocrine Therapy in Operable Breast Cancer. Prep for Pandemic

  2020cites this paper
• Patient preferences for locoregional therapy in early-stage breast cancer

  2020influential citation
• Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group

  2020cites this paper
• Process evaluation of the Bridging the Age Gap in Breast Cancer decision support intervention cluster randomised trial

  2020cites this paper
• Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study.

  2020cites this paper
• Differences in clinicopathologic features and subtype distribution of invasive breast cancer between elderly and non-elderly women

  2020cites this paper
• The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer

  2020cites this paper
• Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray

  2020cites this paper
• Efficient development and usability testing of decision support interventions for older women with breast cancer

  2019cites this paper
• Efficient development and usability testing of decision support interventions for older women with breast cancer

  2019cites this paper
• Super-elderly patient-specific perioperative complications in breast cancer surgery

  2019cites this paper
• Oncologic Results of Breast Conserving Surgery under Procedural Sedation in Elderly Patients

  2019cites this paper
• Primary Endocrine Therapy

  2019cites this paper
• Efficient development and usability testing of decision support interventions for older women with breast cancer

  2019cites this paper
• Opportunities and priorities for breast surgical research.

  2018cites this paper
• Karcinom prsu ve vyšším věku

  2018cites this paper
• Breast cancer in octogenarian. Are we doing our best? A population-registry based study.

  2018cites this paper
• Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database

  2018cites this paper
• Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

  2018cites this paper
• Breast cancer treatment in women over the age of 80: A tailored approach.

  2018cites this paper
• Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

  2018cites this paper
• Breast Cancer Management in the Older Woman

  2018cites this paper
• Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation

  2018cites this paper
• Endocrine therapy for cancer

  2018cites this paper
• Surgical Management of Early Breast Cancer

  2018cites this paper
• Selective vs Nonselective Nonsteroidal Anti-inflammatory Drugs and Anastomotic Leakage After Colorectal Surgery

  2017cites this paper
• A systematic review of generic and breast cancer specific life expectancy models in the elderly.

  2017cites this paper
• Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer

  2017cites this paper
• Clinicopathological features of patients with breast cancer aged 70 years or over.

  2017cites this paper
• Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial

  2017cites this paper
• Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery.

  2017cites this paper
• Controversial issues in the management of older adults with early breast cancer.

  2017cites this paper
• Decision-making in older women with breast cancer : a mixed methods study

  2017cites this paper
• Neoadjuvant endocrine therapy in breast cancer patients

  2017cites this paper
• Evidence-based maatwerk voor ouderen met kanker

  2017cites this paper
• Pre-operative Endocrine Therapy

  2017cites this paper
• What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment.

  2017cites this paper
• Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives

  2016cites this paper
• The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics.

  2016cites this paper
• Moduladores selectivos de los receptores estrogénicos (MSRE)

  2016cites this paper
• The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition

  2016cites this paper
• Adjuvant systemic therapy in older women with breast cancer

  2016cites this paper
• How does surgery compare with tamoxifen in elderly women (70 years plus) with operable primary breast cancer

  2016cites this paper